(Q38353360)

2 September 2017

Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine (English)

1 reference

2 September 2017

1 reference

Uri Galili

1

1 reference

2 September 2017

Zhao-chun Chen

series ordinal

2

1 reference

2 September 2017

Koen DeGeest

series ordinal

3

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

2 September 2017

1 reference

2 September 2017

90

1 reference

2 September 2017

100-108

1 reference

2 September 2017

1

1 reference

Spinning molecular immunology into successful immunotherapy

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

1 reference

7 January 2021

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Mechanisms of antigen uptake for presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Tolerance and ways to break it.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Function and heterogeneity of human Fc receptors for immunoglobulin G.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Fc receptors are required in passive and active immunity to melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

A unique natural human IgG antibody with anti-alpha-galactosyl specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Synthesis of alpha-gal epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on human tumor cells by recombinant alpha1,3galactosyltransferase produced in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Immunochemical studies of the combining sites of the two isolectins, A4 and B4, isolated from Bandeiraea simplicifolia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of alpha-galactosidase-treated porcine cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Specific immunotherapy with neuraminidase-modified leukemic cells: experimental and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

Transplantation of porcine fetal pancreas to diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2803%2900148-3

7 January 2021

10.1016/S0090-8258(03)00148-3

Identifiers

DOI

1 reference

2 September 2017

1 reference